Bitrobius Genetics
Biotechnology
Early Stage
2021
www.bitrobius.com
Bitrobius is a start-up biotechnology company developing a synthetic gene transfer technology for use in the research & development, manufacture and delivery of cell and gene therapies and vaccines.
Cell and gene therapy is an emerging and fast-growing area of biotechnology and drug development. Bitrobius has a very novel platform technology to increase the efficiency of gene transfer that could be applied to many areas of cell and gene therapy with multiple commercialisation routes.